Due to a policy decision in 2010 by the U.S. Food and Drug Administration (FDA), the price of a prescription for the therapeutic gout drug colchicine increased nearly 16-fold from $11.25 in 2009 to $190.49 in 2011.
Colchicine prescriptions dropped sharply and patient visits for gout-related symptoms increased significantly after a 2010 US Food and Drug Administration ruling that enabled a price spike.
After winning our Seema S. Sonnad Emerging Leader in Managed Care Research Award, these researchers have gone on to make substantial impacts in the field of managed care and mentor the next generation of investigators.